BioCentury
ARTICLE | Clinical News

Pralatrexate: Completed Phase IIa enrollment

July 13, 2009 7:00 AM UTC

Allos completed enrollment of 201 current/former cigarette smokers who have failed >=1 platinum-based chemotherapy in an international Phase IIb trial evaluating IV pralatrexate given on days 1 and 15...